21 – 29 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2018
-
Mark
Rates of glycaemic deterioration in a real-world population with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference
(
- Contribution to journal › Article
- 2017
-
Mark
Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Predicting glycated hemoglobin levels in the non-diabetic general population : Development and validation of the DIRECTDETECT prediction model-a DIRECT study
(
- Contribution to journal › Article
- 2016
-
Mark
Statistical power considerations in genotype-based recall randomized controlled trials
(
- Contribution to journal › Article
- 2014
-
Mark
Clinical and Genetic Determinants of Progression of Type 2 Diabetes: A DIRECT Study
(
- Contribution to journal › Article
-
Mark
Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.
(
- Contribution to journal › Article
- 2013
-
Mark
The CTRB1/2 Locus Affects Diabetes Susceptibility and Treatment via the Incretin Pathway
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »